Shalnova S.A. Comments on the section “Cardiovascular risk estimation” in the 2021 European Society of Cardiology guidelines on cardiovascular disease prevention in clinical practice. Cardiovascular Therapy and Prevention. 2022;21(1):3171. https://doi.org/10.15829/1728-8800-2022-3171
Editor-in-Chief
Drapkina O. M.
Email this article (Login required)
Email the author (Login required) 101000, Moscow, Petroverigsky per., 10, str. 3
National medical research center for therapy and preventive medicine
Тел: +7 (499) 553 67 78
Editorial office Cardiovascular Therapy and Prevention
Processing of personal data
